Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Clinical trial NCT06271057 · RECRUITING

Trial details

NCT number: NCT06271057
Sponsor: The Lymphoma Academic Research Organisation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma Refractory Refractory Primary Mediastinal Large B-Cell Lymphoma Refractory Transformed B-cell Non-Hodgkin Lymphoma Refractory High Grade B-Cell Lymphoma

Start date: 2024-06-14
Primary completion: 2027-03-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.